Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1

Identifieur interne : 000474 ( Istex/Corpus ); précédent : 000473; suivant : 000475

Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1

Auteurs : Douglas S. Zatechka Jr. ; Nagendra R. Hegde ; Kandasamy Hariharan ; S. Srikumaran

Source :

RBID : ISTEX:DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F

English descriptors

Abstract

Abstract: Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8+ cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2Dd- and H-2Kd-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2Dd and H-2Kd ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the Dd molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.

Url:
DOI: 10.1016/S0264-410X(98)00251-5

Links to Exploration step

ISTEX:DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
<author>
<name sortKey="Zatechka Jr, Douglas S" sort="Zatechka Jr, Douglas S" uniqKey="Zatechka Jr D" first="Douglas S." last="Zatechka Jr.">Douglas S. Zatechka Jr.</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hegde, Nagendra R" sort="Hegde, Nagendra R" uniqKey="Hegde N" first="Nagendra R." last="Hegde">Nagendra R. Hegde</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hariharan, Kandasamy" sort="Hariharan, Kandasamy" uniqKey="Hariharan K" first="Kandasamy" last="Hariharan">Kandasamy Hariharan</name>
<affiliation>
<mods:affiliation>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Srikumaran, S" sort="Srikumaran, S" uniqKey="Srikumaran S" first="S." last="Srikumaran">S. Srikumaran</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0264-410X(98)00251-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000474</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000474</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
<author>
<name sortKey="Zatechka Jr, Douglas S" sort="Zatechka Jr, Douglas S" uniqKey="Zatechka Jr D" first="Douglas S." last="Zatechka Jr.">Douglas S. Zatechka Jr.</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hegde, Nagendra R" sort="Hegde, Nagendra R" uniqKey="Hegde N" first="Nagendra R." last="Hegde">Nagendra R. Hegde</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hariharan, Kandasamy" sort="Hariharan, Kandasamy" uniqKey="Hariharan K" first="Kandasamy" last="Hariharan">Kandasamy Hariharan</name>
<affiliation>
<mods:affiliation>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Srikumaran, S" sort="Srikumaran, S" uniqKey="Srikumaran S" first="S." last="Srikumaran">S. Srikumaran</name>
<affiliation>
<mods:affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">7–8</biblScope>
<biblScope unit="page" from="686">686</biblScope>
<biblScope unit="page" to="694">694</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Adjuvant</term>
<term>Allele</term>
<term>Aspms</term>
<term>Assay</term>
<term>Bovine</term>
<term>Bovine herpesvirus</term>
<term>Cell epitopes</term>
<term>Ctls</term>
<term>Cytotoxic</term>
<term>Cytotoxicity assay</term>
<term>Epitope</term>
<term>Error bars</term>
<term>Glycoprotein</term>
<term>Herpesvirus</term>
<term>Immunization</term>
<term>Immunol</term>
<term>Individual peptides</term>
<term>Lymphocyte</term>
<term>Lysed</term>
<term>Lysis</term>
<term>Maximum release</term>
<term>Molecule</term>
<term>Murine</term>
<term>Native peptides</term>
<term>Particular class</term>
<term>Peptide</term>
<term>Peptide motif</term>
<term>Peptide motifs</term>
<term>Recombinant</term>
<term>Spontaneous release</term>
<term>Standard deviations</term>
<term>Syngeneic</term>
<term>Synthetic peptides</term>
<term>Target cells</term>
<term>Vaccine</term>
<term>Viral</term>
<term>Viral immunol</term>
<term>Viral peptides</term>
<term>Virol</term>
<term>Zatechka</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8+ cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2Dd- and H-2Kd-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2Dd and H-2Kd ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the Dd molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<keywords>
<teeft>
<json:string>epitope</json:string>
<json:string>ctls</json:string>
<json:string>peptide</json:string>
<json:string>cytotoxic</json:string>
<json:string>lymphocyte</json:string>
<json:string>viral</json:string>
<json:string>murine</json:string>
<json:string>vaccine</json:string>
<json:string>lysed</json:string>
<json:string>glycoprotein</json:string>
<json:string>immunol</json:string>
<json:string>virol</json:string>
<json:string>aspms</json:string>
<json:string>syngeneic</json:string>
<json:string>recombinant</json:string>
<json:string>herpesvirus</json:string>
<json:string>lysis</json:string>
<json:string>zatechka</json:string>
<json:string>allele</json:string>
<json:string>bovine herpesvirus</json:string>
<json:string>synthetic peptides</json:string>
<json:string>adjuvant</json:string>
<json:string>assay</json:string>
<json:string>maximum release</json:string>
<json:string>peptide motifs</json:string>
<json:string>bovine</json:string>
<json:string>standard deviations</json:string>
<json:string>cell epitopes</json:string>
<json:string>target cells</json:string>
<json:string>error bars</json:string>
<json:string>individual peptides</json:string>
<json:string>immunization</json:string>
<json:string>native peptides</json:string>
<json:string>peptide motif</json:string>
<json:string>spontaneous release</json:string>
<json:string>cytotoxicity assay</json:string>
<json:string>viral peptides</json:string>
<json:string>viral immunol</json:string>
<json:string>particular class</json:string>
<json:string>molecule</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Douglas S. Zatechka, Jr.</name>
<affiliations>
<json:string>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nagendra R. Hegde</name>
<affiliations>
<json:string>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Kandasamy Hariharan</name>
<affiliations>
<json:string>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>S. Srikumaran</name>
<affiliations>
<json:string>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Allele-specific peptide motif</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>BHV-1</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>CTL epitope</value>
</json:item>
</subject>
<arkIstex>ark:/67375/6H6-JBNNRNX8-2</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<abstract>Abstract: Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8+ cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2Dd- and H-2Kd-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2Dd and H-2Kd ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the Dd molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.</abstract>
<qualityIndicators>
<score>8.908</score>
<pdfWordCount>5414</pdfWordCount>
<pdfCharCount>34207</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>9</pdfPageCount>
<pdfPageSize>595 x 842 pts (A4)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>159</abstractWordCount>
<abstractCharCount>1107</abstractCharCount>
<keywordCount>3</keywordCount>
</qualityIndicators>
<title>Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
<pmid>
<json:string>10067674</json:string>
</pmid>
<pii>
<json:string>S0264-410X(98)00251-5</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<title>Vaccine</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>1999</publicationDate>
<issn>
<json:string>0264-410X</json:string>
</issn>
<pii>
<json:string>S0264-410X(00)X0073-4</json:string>
</pii>
<volume>17</volume>
<issue>7–8</issue>
<pages>
<first>686</first>
<last>694</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1999</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Department of Veterinary and Biomedical Sciences</json:string>
<json:string>Jackson Laboratory, Bar Harbor, ME</json:string>
<json:string>University of Nebraska Agricultural Research Division</json:string>
<json:string>Scripps Laboratories</json:string>
<json:string>CytRx Corporation</json:string>
<json:string>Use Committee of the University of Nebraska-Lincoln</json:string>
<json:string>IDEC Pharmaceuticals Corporation, San Diego</json:string>
<json:string>Elsevier Science Ltd.</json:string>
<json:string>University of Nebraska-Lincoln</json:string>
<json:string>Veterinary Diagnostic Center</json:string>
<json:string>American Type Culture Collection</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>Ruben Donis</json:string>
<json:string>Irvine Scienti</json:string>
<json:string>To</json:string>
<json:string>La Jolla</json:string>
<json:string>L. Peptides</json:string>
</persName>
<placeName>
<json:string>Durham</json:string>
<json:string>IL</json:string>
<json:string>Huntsville</json:string>
<json:string>GA</json:string>
<json:string>NC</json:string>
<json:string>NE</json:string>
<json:string>CA</json:string>
<json:string>MA</json:string>
<json:string>AL</json:string>
<json:string>Norcross</json:string>
<json:string>Cambridge</json:string>
<json:string>Arlington Heights</json:string>
<json:string>Mountain View</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>D.S. Zatechka et al.</json:string>
<json:string>[4]</json:string>
<json:string>[45]</json:string>
<json:string>[29]</json:string>
<json:string>[6]</json:string>
<json:string>[22]</json:string>
<json:string>[32, 33]</json:string>
<json:string>[28]</json:string>
<json:string>[6, 44]</json:string>
<json:string>[17, 18]</json:string>
<json:string>[1]</json:string>
<json:string>[21]</json:string>
<json:string>[39, 40]</json:string>
<json:string>Storkus et al. [20]</json:string>
<json:string>[49]</json:string>
<json:string>[50, 51]</json:string>
<json:string>[31]</json:string>
<json:string>[46, 47]</json:string>
<json:string>[5]</json:string>
<json:string>[48]</json:string>
<json:string>[52]</json:string>
<json:string>[7]</json:string>
<json:string>[36]</json:string>
<json:string>[42, 43]</json:string>
<json:string>[2]</json:string>
<json:string>[46]</json:string>
<json:string>[19]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/6H6-JBNNRNX8-2</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - medicine, research & experimental</json:string>
<json:string>2 - immunology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - biomedical research</json:string>
<json:string>3 - virology</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Infectious Diseases</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Public Health, Environmental and Occupational Health</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Veterinary</json:string>
<json:string>3 - General Veterinary</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Immunology and Microbiology</json:string>
<json:string>3 - General Immunology and Microbiology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Medicine</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences biologiques fondamentales et appliquees. psychologie</json:string>
<json:string>4 - microbiologie</json:string>
</inist>
</categories>
<publicationDate>1999</publicationDate>
<copyrightDate>1999</copyrightDate>
<doi>
<json:string>10.1016/S0264-410X(98)00251-5</json:string>
</doi>
<id>DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability>
<licence>
<p>©1999 Elsevier Science Ltd</p>
</licence>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</p>
</availability>
<date>1999</date>
</publicationStmt>
<notesStmt>
<note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note type="content">Fig. 1: The ability of the synthetic peptides to bind class I molecules. BALB/3T3 cells were treated with citrate–phosphate buffer, pH 3.3, for 20 s. Dissociation of the native peptides (stripping) was monitored by flow cytometry using antibodies that bind H-2d molecules only in the presence of bound peptides (TIB-126) or irrespective of peptide binding (HB87). The ability of the synthetic peptides to individually reconstitute the TIB-126 epitope was tested by incubating the stripped cells with peptides, in the presence of human β2-microglobulin. Results are expressed as fluorescence index (FI) calculated as follows: FI=(Mean sample fluorescence−Mean background fluorescence)/(Mean background fluorescence)×100, where background refers to peptide-stripped cells and sample refers to peptide-pulsed cells. The error bars indicate standard deviations of the means.</note>
<note type="content">Fig. 2: Immunization of mice with BHV-1 protein or peptides induces BHV-1-specific CTLs. Mice were immunized and boosted with protein (Panel A) or peptides (Panel B), in PROVAX™ or TiterMax, and lymphocytes were harvested from spleen (Panel A) or popliteal lymph nodes (Panel B), respectively. In vitro restimulated effectors were tested against syngeneic targets either pulsed with a cocktail of peptides or not pulsed with the peptides, at the indicated E:T ratios, in a standard 51Cr-release assay. The results are presented as % specific lysis, calculated as follows: % specific lysis=(Sample 51Cr release−Spontaneous 51Cr release)/(Maximum 51Cr release−Spontaneous 51Cr release) where spontaneous and maximum release refer to no effector and Triton X-100-treated samples, respectively. Spontaneous release was less than 20% of maximum release in all cases. The error bars indicate standard deviations of the means.</note>
<note type="content">Fig. 3: Identification of H-2Dd-restricted CTL epitopes of BHV-1. CTLs derived as described in Fig. 2B, were tested in a 51Cr-release assay using syngeneic cells pulsed with individual peptides at the indicated E:T ratios. The negative control peptide was a nonamer from BVDV gp53. The spontaneous release was less than 18% of maximum release in all cases. The error bars indicate standard deviations of the means. The means were statistically significant when no antigen was compared individually with peptides 1, 6 and 7, but not significant between no antigen and peptide (p<0.05).</note>
<note type="content">Fig. 4: BHV-1-specific CTLs are H-2Dd-restricted. CTLs obtained as described in Fig. 2, were tested in a 51Cr-release assay using targets pulsed with a pool of peptides 1, 6 and 7. The results are presented as described in Fig. 2. Spontaneous release was less than 12% of maximum release in all cases. (A) CTLs are class I-restricted. BALB/3T3 cells that do not express class II molecules were used as targets. (B) CTLs are H-2Dd-restricted. Syngeneic (P815, H-2d) and allogeneic (EL-4, H-2b) targets were used. The error bars indicate standard deviations of the means.</note>
<note type="content">Table 1: The allele-specific peptide motifs (ASPMs) of the MHC class I products utilized</note>
<note type="content">Table 2: Peptides synthesized in this study</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Douglas S.</forename>
<surname>Zatechka, Jr.</surname>
</persName>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Nagendra R.</forename>
<surname>Hegde</surname>
</persName>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">Kandasamy</forename>
<surname>Hariharan</surname>
</persName>
<affiliation>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">S.</forename>
<surname>Srikumaran</surname>
</persName>
<note type="correspondence">
<p>Corresponding author. Tel.: +1-402-472-3319; fax: +1-402-472-9690</p>
</note>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
</author>
<idno type="istex">DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F</idno>
<idno type="ark">ark:/67375/6H6-JBNNRNX8-2</idno>
<idno type="DOI">10.1016/S0264-410X(98)00251-5</idno>
<idno type="PII">S0264-410X(98)00251-5</idno>
</analytic>
<monogr>
<title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="pISSN">0264-410X</idno>
<idno type="PII">S0264-410X(00)X0073-4</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999"></date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">7–8</biblScope>
<biblScope unit="page" from="686">686</biblScope>
<biblScope unit="page" to="694">694</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1999</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Abstract: Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8+ cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2Dd- and H-2Kd-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2Dd and H-2Kd ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the Dd molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.</p>
</abstract>
<textClass>
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>Allele-specific peptide motif</term>
</item>
<item>
<term>BHV-1</term>
</item>
<item>
<term>CTL epitope</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1998-06-22">Modified</change>
<change when="1999">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType">
<istex:entity SYSTEM="gr1" NDATA="IMAGE" name="gr1"></istex:entity>
<istex:entity SYSTEM="gr2" NDATA="IMAGE" name="gr2"></istex:entity>
<istex:entity SYSTEM="gr3" NDATA="IMAGE" name="gr3"></istex:entity>
<istex:entity SYSTEM="gr4" NDATA="IMAGE" name="gr4"></istex:entity>
</istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla">
<item-info>
<jid>JVAC</jid>
<aid>1220</aid>
<ce:pii>S0264-410X(98)00251-5</ce:pii>
<ce:doi>10.1016/S0264-410X(98)00251-5</ce:doi>
<ce:copyright year="1999" type="full-transfer">Elsevier Science Ltd</ce:copyright>
</item-info>
<head>
<ce:title>Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>Douglas S.</ce:given-name>
<ce:surname>Zatechka</ce:surname>
<ce:suffix>Jr.</ce:suffix>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Nagendra R.</ce:given-name>
<ce:surname>Hegde</ce:surname>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Kandasamy</ce:given-name>
<ce:surname>Hariharan</ce:surname>
<ce:cross-ref refid="AFF2">b</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>S.</ce:given-name>
<ce:surname>Srikumaran</ce:surname>
<ce:cross-ref refid="AFF1">a</ce:cross-ref>
<ce:cross-ref refid="CORR1">*</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1">
<ce:label>a</ce:label>
<ce:textfn>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2">
<ce:label>b</ce:label>
<ce:textfn>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</ce:textfn>
</ce:affiliation>
<ce:correspondence id="CORR1">
<ce:label>*</ce:label>
<ce:text>Corresponding author. Tel.: +1-402-472-3319; fax: +1-402-472-9690</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="2" month="4" year="1998"></ce:date-received>
<ce:date-revised day="22" month="6" year="1998"></ce:date-revised>
<ce:date-accepted day="22" month="6" year="1998"></ce:date-accepted>
<ce:abstract>
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8
<ce:sup>+</ce:sup>
cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2D
<ce:sup>d</ce:sup>
- and H-2K
<ce:sup>d</ce:sup>
-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2D
<ce:sup>d</ce:sup>
and H-2K
<ce:sup>d</ce:sup>
ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the D
<ce:sup>d</ce:sup>
molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
<ce:keywords class="keyword">
<ce:section-title>Keywords</ce:section-title>
<ce:keyword>
<ce:text>Allele-specific peptide motif</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>BHV-1</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>CTL epitope</ce:text>
</ce:keyword>
</ce:keywords>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1</title>
</titleInfo>
<name type="personal">
<namePart type="given">Douglas S.</namePart>
<namePart type="family">Zatechka, Jr.</namePart>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nagendra R.</namePart>
<namePart type="family">Hegde</namePart>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Kandasamy</namePart>
<namePart type="family">Hariharan</namePart>
<affiliation>IDEC Pharmaceuticals Corporation, San Diego, CA 92121, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S.</namePart>
<namePart type="family">Srikumaran</namePart>
<affiliation>Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Fair Street and East Campus Loop, Lincoln, NE 68583-0905, USA</affiliation>
<description>Corresponding author. Tel.: +1-402-472-3319; fax: +1-402-472-9690</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1999</dateIssued>
<dateModified encoding="w3cdtf">1998-06-22</dateModified>
<copyrightDate encoding="w3cdtf">1999</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract lang="en">Abstract: Major histocompatibility complex (MHC) class I molecules present endogenously derived viral peptides to CD8+ cytotoxic T-lymphocytes (CTLs). The objective of this study was to identify the H-2Dd- and H-2Kd-restricted CTL epitopes of bovine herpesvirus 1 (BHV-1), based on the allele-specific peptide motifs (ASPMs) of the above class I molecules. Nine sequences conforming to the H-2Dd and H-2Kd ASPMs were identified on BHV-1 proteins, and the respective peptides were synthesized. Five of these peptides exhibited moderate to strong binding to the Dd molecule. CTLs generated by BALB/c mice immunized with BHV-1 proteins emulsified in a suitable adjuvant effectively lysed peptide-pulsed syngeneic targets, indicating that these epitopes were generated in vivo. Mice immunized with these peptides emulsified in a suitable adjuvant also developed anti-BHV-1 CTLs. These CTLs identified three veritable CTL epitopes among the “potential epitopes” synthesized based on the ASPMs. The elucidation of the CTL epitopes of BHV-1 should aid in the development of efficacious vaccines against this virus.</abstract>
<note type="content">Fig. 1: The ability of the synthetic peptides to bind class I molecules. BALB/3T3 cells were treated with citrate–phosphate buffer, pH 3.3, for 20 s. Dissociation of the native peptides (stripping) was monitored by flow cytometry using antibodies that bind H-2d molecules only in the presence of bound peptides (TIB-126) or irrespective of peptide binding (HB87). The ability of the synthetic peptides to individually reconstitute the TIB-126 epitope was tested by incubating the stripped cells with peptides, in the presence of human β2-microglobulin. Results are expressed as fluorescence index (FI) calculated as follows: FI=(Mean sample fluorescence−Mean background fluorescence)/(Mean background fluorescence)×100, where background refers to peptide-stripped cells and sample refers to peptide-pulsed cells. The error bars indicate standard deviations of the means.</note>
<note type="content">Fig. 2: Immunization of mice with BHV-1 protein or peptides induces BHV-1-specific CTLs. Mice were immunized and boosted with protein (Panel A) or peptides (Panel B), in PROVAX™ or TiterMax, and lymphocytes were harvested from spleen (Panel A) or popliteal lymph nodes (Panel B), respectively. In vitro restimulated effectors were tested against syngeneic targets either pulsed with a cocktail of peptides or not pulsed with the peptides, at the indicated E:T ratios, in a standard 51Cr-release assay. The results are presented as % specific lysis, calculated as follows: % specific lysis=(Sample 51Cr release−Spontaneous 51Cr release)/(Maximum 51Cr release−Spontaneous 51Cr release) where spontaneous and maximum release refer to no effector and Triton X-100-treated samples, respectively. Spontaneous release was less than 20% of maximum release in all cases. The error bars indicate standard deviations of the means.</note>
<note type="content">Fig. 3: Identification of H-2Dd-restricted CTL epitopes of BHV-1. CTLs derived as described in Fig. 2B, were tested in a 51Cr-release assay using syngeneic cells pulsed with individual peptides at the indicated E:T ratios. The negative control peptide was a nonamer from BVDV gp53. The spontaneous release was less than 18% of maximum release in all cases. The error bars indicate standard deviations of the means. The means were statistically significant when no antigen was compared individually with peptides 1, 6 and 7, but not significant between no antigen and peptide (p<0.05).</note>
<note type="content">Fig. 4: BHV-1-specific CTLs are H-2Dd-restricted. CTLs obtained as described in Fig. 2, were tested in a 51Cr-release assay using targets pulsed with a pool of peptides 1, 6 and 7. The results are presented as described in Fig. 2. Spontaneous release was less than 12% of maximum release in all cases. (A) CTLs are class I-restricted. BALB/3T3 cells that do not express class II molecules were used as targets. (B) CTLs are H-2Dd-restricted. Syngeneic (P815, H-2d) and allogeneic (EL-4, H-2b) targets were used. The error bars indicate standard deviations of the means.</note>
<note type="content">Table 1: The allele-specific peptide motifs (ASPMs) of the MHC class I products utilized</note>
<note type="content">Table 2: Peptides synthesized in this study</note>
<subject>
<genre>Keywords</genre>
<topic>Allele-specific peptide motif</topic>
<topic>BHV-1</topic>
<topic>CTL epitope</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Vaccine</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>JVAC</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1999</dateIssued>
</originInfo>
<identifier type="ISSN">0264-410X</identifier>
<identifier type="PII">S0264-410X(00)X0073-4</identifier>
<part>
<date>1999</date>
<detail type="volume">
<number>17</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>7–8</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages">
<start>617</start>
<end>1014</end>
</extent>
<extent unit="pages">
<start>686</start>
<end>694</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F</identifier>
<identifier type="ark">ark:/67375/6H6-JBNNRNX8-2</identifier>
<identifier type="DOI">10.1016/S0264-410X(98)00251-5</identifier>
<identifier type="PII">S0264-410X(98)00251-5</identifier>
<accessCondition type="use and reproduction" contentType="copyright">©1999 Elsevier Science Ltd</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
<recordOrigin>Elsevier Science Ltd, ©1999</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-JBNNRNX8-2/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000474 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000474 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:DFF0F9A5B5E7DDFB9AF6408CCA95D8659945BC6F
   |texte=   Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021